Bellevue Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,850,000
| Closed | -$36.4M | – | 226 |
|
|
2020
Q3 | $36.4M | Hold |
3,850,000
| – | – | 0.5% | 57 |
|
|
2020
Q2 | $34.5M | Hold |
3,850,000
| – | – | 0.49% | 52 |
|
|
2020
Q1 | $24.5M | Hold |
3,850,000
| – | – | 0.48% | 57 |
|
|
2019
Q4 | $32.2M | Buy |
3,850,000
+200,000
| +5% | +$1.67M | 0.51% | 49 |
|
|
2019
Q3 | $33M | Hold |
3,650,000
| – | – | 0.61% | 43 |
|
|
2019
Q2 | $39.3M | Buy |
+3,650,000
| New | +$39.3M | 0.67% | 38 |
|